Abiomed posts 33 percent increase in revenue as Impella devices gain market momentum
Danvers, Massachusetts-based Abiomed has posted a 33 percent increase in total sales in its fourth quarter, which exceeded market watchers’ expectations, reported The Motley Fool.
Abiomed raked in $124.7 million in the fourth quarter of this year, compared with $94 million in 2016. Adjusted earnings per share are $.033, compared to $0.24 the same time last year.
The company attributes the growth to increasing sales of its Impella heart pumps.
To read the full story, follow the link below: